Class III — Low Risk

Low risk — use of or exposure to this product is not likely to cause adverse health consequences.

ARCHITECT BNP Controls Ptoduct Usage: The ARCHITECT BNP Controls are Recalled by Abbott Laboratories Due to Presence of a time dependent, stability drift in...

Date: May 24, 2019
Company: Abbott Laboratories
Status: Terminated
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Abbott Laboratories directly.

Affected Products

ARCHITECT BNP Controls Ptoduct Usage: The ARCHITECT BNP Controls are for the estimation of test precision and the detection of systematic analytical deviations of the ARCHITECT iSystem (reagents, calibrators and instrument), when used for the quantitative determination of human B type natriuretic peptide (BNP) in human EDTA plasma.

Quantity: 6,623 units

Why Was This Recalled?

Presence of a time dependent, stability drift in patient and control results returned from ARCHITECT BNP testing.

Where Was This Sold?

This product was distributed nationwide across all 50 states.

Affected (51 states)Not affected

About Abbott Laboratories

Abbott Laboratories has 124 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report